Rewriting the prognosis of multiple sclerosis in Brazil: a 25-year perspective on evolving diagnostic criteria
Saved in:
| Main Authors: | Dagoberto Callegaro, Guilherme Diogo Silva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2025-06-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809937 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding MOG antibody-associated disease in Brazil
by: Dagoberto Callegaro, et al.
Published: (2023-11-01) -
Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
by: Guilherme Diogo Silva, et al.
Published: (2025-09-01) -
Oral fingolimod to treat multiple sclerosis: see your cardiologist first
by: Douglas Kazutoshi Sato, et al.
Published: (2014-09-01) -
Prevalence of multiple sclerosis in key cities of Brazil: a study in Passo Fundo, Southern Brazil
by: Giordani Rodrigues dos Passos, et al.
Published: (2021-09-01) -
The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil
by: Leonardo Zumerkorn Pipek, et al.
Published: (2024-01-01)